- Home
- APLT vs CAL Comparison
APLT vs CAL Comparison
Compare APLT & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- CAL
- Stock Information
- Founded
- APLT 2016
- CAL 1878
- Country
- APLT United States
- CAL United States
- Employees
- APLT N/A
- CAL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- APLT Health Care
- CAL Consumer Discretionary
- Exchange
- APLT Nasdaq
- CAL Nasdaq
- Market Cap
- APLT 52.9M
- CAL 520.3M
- IPO Year
- APLT 2019
- CAL N/A
- Fundamental
- Price
- APLT $0.33
- CAL $14.03
- Analyst Decision
- APLT Buy
- CAL Hold
- Analyst Count
- APLT 7
- CAL 1
- Target Price
- APLT $6.10
- CAL $14.00
- AVG Volume (30 Days)
- APLT 2.3M
- CAL 1.0M
- Earning Date
- APLT 08-06-2025
- CAL 05-29-2025
- Dividend Yield
- APLT N/A
- CAL 2.00%
- EPS Growth
- APLT N/A
- CAL N/A
- EPS
- APLT N/A
- CAL 2.43
- Revenue
- APLT $265,000.00
- CAL $2,677,706,000.00
- Revenue This Year
- APLT $1,768.13
- CAL N/A
- Revenue Next Year
- APLT $292.85
- CAL $3.48
- P/E Ratio
- APLT N/A
- CAL $5.78
- Revenue Growth
- APLT N/A
- CAL N/A
- 52 Week Low
- APLT $0.30
- CAL $12.09
- 52 Week High
- APLT $10.62
- CAL $44.51
- Technical
- Relative Strength Index (RSI)
- APLT 43.25
- CAL 53.79
- Support Level
- APLT $0.30
- CAL $12.14
- Resistance Level
- APLT $0.36
- CAL $12.83
- Average True Range (ATR)
- APLT 0.03
- CAL 0.70
- MACD
- APLT -0.00
- CAL 0.22
- Stochastic Oscillator
- APLT 22.22
- CAL 93.27
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.